Literature DB >> 19400026

An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19400026

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


× No keyword cloud information.
  21 in total

1.  Immunization in Canada: a 6-year update.

Authors:  Scott A Halperin; Kiersten Pianosi
Journal:  J Can Chiropr Assoc       Date:  2010-06

2.  Challenges to the surveillance of meningococcal disease in an era of declining incidence in montréal, Québec.

Authors:  Ruwan Ratnayake; Robert Allard
Journal:  Can J Public Health       Date:  2013-05-14

3.  Increase in Neisseria meningitidis serogroup W invasive disease in Canada: 2009-2016.

Authors:  Rsw Tsang; L Hoang; G J Tyrrell; G Horsman; P Van Caeseele; F Jamieson; B Lefebvre; D Haldane; R R Gad; G J German; G Zahariadis
Journal:  Can Commun Dis Rep       Date:  2017-07-06

4.  From genes to vaccine: A breakthrough in the prevention of meningococcal group B disease.

Authors:  Maria Major; Steven Moss; Ronald Gold
Journal:  Paediatr Child Health       Date:  2011-10       Impact factor: 2.253

5.  Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.

Authors:  A Khatami; A Peters; H Robinson; N Williams; A Thompson; H Findlow; A J Pollard; M D Snape
Journal:  Clin Vaccine Immunol       Date:  2011-10-28

6.  UPDATE ON THE USE OF QUADRIVALENT CONJUGATE MENINGOCOCCAL VACCINES: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  This Statement Was Prepared By Dr B Warshawsky
Journal:  Can Commun Dis Rep       Date:  2013-01-02

7.  Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates.

Authors:  Alan Kimura; Daniela Toneatto; Annett Kleinschmidt; Huajun Wang; Peter Dull
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

8.  A new meningococcal conjugate vaccine: What should physicians know and do?

Authors:  R Bortolussi; M Salvadori
Journal:  Paediatr Child Health       Date:  2009-10       Impact factor: 2.253

9.  Effect of increased CRM₁₉₇ carrier protein dose on meningococcal C bactericidal antibody response.

Authors:  Lucia H Lee; Milan S Blake
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

Review 10.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.